C111H127N39O15S7 — CID 159731087
1-methyl-4-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole;N-methyl-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-[3-(pyrrolidin-1-ylmethyl)azetidin-1-yl]pyridine (PubChem CID 159731087) has the molecular formula C111H127N39O15S7 and a molecular weight of 2471.96 g/mol. Its IUPAC name is 1-methyl-4-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole;N-methyl-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-[3-(pyrrolidin-1-ylmethyl)azetidin-1-yl]pyridine.
| Compound Name | 1-methyl-4-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole;N-methyl-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-[3-(pyrrolidin-1-ylmethyl)azetidin-1-yl]pyridine |
|---|---|
| PubChem CID | 159731087 |
| Molecular Formula | C111H127N39O15S7 |
| Molecular Weight | 2471.96 g/mol |
| Exact Mass | 2469.84 |
| IUPAC Name | 1-methyl-4-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole;N-methyl-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-N-(2-pyrrolidin-1-ylethyl)pyridin-2-amine;2-(3-methylsulfonylazetidin-1-yl)-5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]pyridine;3-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]propan-1-amine;1-[5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-pyridinyl]pyrrolidin-3-ol;5-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)phenyl]-2-[3-(pyrrolidin-1-ylmethyl)azetidin-1-yl]pyridine |
| SMILES | CN(CCN1CCCC1)c1ccc(-c2cccc(S(C)(=O)=O)c2-c2nn[nH]n2)cn1.CN1CCC2C1CCN2c1ccc(-c2cccc(S(C)(=O)=O)c2-c2nn[nH]n2)cn1.CS(=O)(=O)c1cccc(-c2ccc(CCCN)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC(CN4CCCC4)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CC(S(C)(=O)=O)C3)nc2)c1-c1nn[nH]n1.CS(=O)(=O)c1cccc(-c2ccc(N3CCC(O)C3)nc2)c1-c1nn[nH]n1 |
| InChI | InChI=1S/C21H25N7O2S.C20H23N7O2S.C20H25N7O2S.C17H18N6O4S2.C17H18N6O3S.C16H18N6O2S/c1-31(29,30)18-6-4-5-17(20(18)21-23-25-26-24-21)16-7-8-19(22-11-16)28-13-15(14-28)12-27-9-2-3-10-27;1-26-10-8-16-15(26)9-11-27(16)18-7-6-13(12-21-18)14-4-3-5-17(30(2,28)29)19(14)20-22-24-25-23-20;1-26(12-13-27-10-3-4-11-27)18-9-8-15(14-21-18)16-6-5-7-17(30(2,28)29)19(16)20-22-24-25-23-20;1-28(24,25)12-9-23(10-12)15-7-6-11(8-18-15)13-4-3-5-14(29(2,26)27)16(13)17-19-21-22-20-17;1-27(25,26)14-4-2-3-13(16(14)17-19-21-22-20-17)11-5-6-15(18-9-11)23-8-7-12(24)10-23;1-25(23,24)14-6-2-5-13(15(14)16-19-21-22-20-16)11-7-8-12(18-10-11)4-3-9-17/h4-8,11,15H,2-3,9-10,12-14H2,1H3,(H,23,24,25,26);3-7,12,15-16H,8-11H2,1-2H3,(H,22,23,24,25);5-9,14H,3-4,10-13H2,1-2H3,(H,22,23,24,25);3-8,12H,9-10H2,1-2H3,(H,19,20,21,22);2-6,9,12,24H,7-8,10H2,1H3,(H,19,20,21,22);2,5-8,10H,3-4,9,17H2,1H3,(H,19,20,21,22) |
| InChIKey | NBFYMTQVAYSSGH-UHFFFAOYSA-N |
| XLogP | 8.04 |
| TPSA | 715.25 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 48 |
| Rotatable Bonds | 32 |
| Heavy Atoms | 172 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2471.96 |
| LogP ≤ 5 | 8.04 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 48 |